TOP HEADLINES

Featured Story

  • Pandemic immune response hints at potential universal flu vax

    The search for a universal flu vaccine has focused on the stem of the lollipop-shaped hemagglutinin of the influenza virus. While the composition of the head changes, the stem is fairly constant from strain to strain. New data shows the body takes advantage of this fact too.

Study reconfirms safety of flu vaccine in pregnant women

Research in the journal Obstetrics and Gynecology found that 74,000 pregnant women who received a flu shot, in any trimester, were no more likely to experience pregnancy complications.

Vaccine calms fears of meningitis becoming AIDS-like epidemic

The recent outbreak of bacterial meningitis among gay and bisexual men in New York City raised fears of an AIDS-like epidemic. Things are different this time though. Health authorities have a vaccine to hold back the spread of the disease.

Researchers aim at trial to test whether BCG vaccine cuts risk of allergies

Researchers have linked rising allergy rates to improved hygiene and asked whether the Bacillus Calmette-Guérin vaccine can reverse the trend. Existing data is inconclusive, but an Australian team has seen enough to run a 1,400-person trial into the effect of the vaccine.

Weak Provenge sales send Dendreon shares tumbling

The miss means Dendreon now expects to fail to achieve its modest goal of growing sales year-on-year.

Sanofi advances C. diff vaccine into PhIII

Sanofi Pasteur is entering an important period for its vaccine business. The success of its big bet on a dengue fever vaccine hangs on upcoming late phase data. And its clostridium difficile jab has just entered Phase III, too.

MORE NEWS

From Our Sister Sites

FierceMarkets Network
FierceDrugDelivery
Platinum-based radiotherapy method zaps cancer with nanomeds

Researchers in Massachusetts have designed nanoparticles that carry platinum-based drugs with a one-two-three punch against tumors--the radiotherapy-triggered vehicles attack a tumor's blood vessels, kill the cells that lead to cancer recurrence and, finally, release a chemo drug that specifically targets the cancer.

FierceBiotech Research
Pluristem's stem cell therapy improves tendon injuries in rats

In rats with tendon injuries that were treated with Pluristem Therapeutics' PLacental eXpanded (PLX) stem cell therapy, animals showed tendon healing at two and four weeks following injection, compared to saline-treated rats, according to the Haifa, Israel-based company.